Covaxin gets emergency use recommendation for children

Covaxin gets emergency use recommendation for children

Newsdesk |
October 12, 2021

The subject expert committee on Covid-19 vaccines has recommended the national drug regulator to grant an emergency use authorisation to Bharat Biotech’s Covaxin for the age group of 2 to 18 years, health ministry sources said.

New Delhi, 12 October 2021

As per news report of The Indian Express, the development is significant as India is just one step away from a Covid-19 vaccine being formally approved for children above the age of 2 years. India’s drug regulator has already approved Zydus Cadila’s DNA Covid-19 vaccine for children aged above 12. The recommendation of the SEC regarding Bharat Biotech’s Covaxin is based on the pediatric study, that is evaluating the safety, reactogenicity, and, immunogenicity of Covaxin. It is being conducted at six sites across the country in healthy volunteers above the age of 2 years.

Source - The Indian Express

If you like the story and if you wish more such stories, support our effort Make a donation.


If you believe investigative journalism is essential to making democracy functional and accountable support us. »